SM
REGN icon

Sabby Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sabby Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,198
Closed -$80.7M – 304
2016
Q4 		$80.7M Buy
2,198
+406
+23% +$154K 4.69% 4
2016
Q3 		$72M Buy
1,792
+632
+54% +$254K 2.7% 7
2016
Q2 		$40.5M Buy
1,160
+572
+97% +$220K 2.11% 10
2016
Q1 		$21.2M Buy
+588
New +$242K 1.06% 19
2015
Q4 		– Sell
-53
Closed -$2.46M – 360
2015
Q3 		$2.46M Sell
53
-854
-94% -$459K 0.1% 134
2015
Q2 		$46.3M Buy
907
+328
+57% +$160K 1.69% 10
2015
Q1 		$26.1M Buy
+579
New +$245K 1.09% 20
2014
Q3 		– Sell
-1,913
Closed -$54M – 288
2014
Q2 		$54M Buy
1,913
+614
+47% +$182K 2.32% 10
2014
Q1 		$39M Buy
1,299
+1,289
+12,890% +$397K 2.19% 11
2013
Q4 		$275K Sell
10
-172
-95% -$49.5K 0.02% 175
2013
Q3 		$5.69M Sell
182
-385
-68% -$101K 0.37% 53
2013
Q2 		$12.8M Buy
+567
New +$132K 0.85% 29

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Sabby Management's REGN Position: Q1 2017 in Review

Sabby Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 162,517 shares — an estimated $59.7M sold.

Sabby Management first reported a position in REGN in Q1 2014 and held it in 7 quarters. The position peaked at $59.7M in Q4 2016. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Sabby Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Sabby Management sold 162,517 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $59.7M.
  • Sabby Management first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 7 quarters.
  • Sabby Management's Regeneron Pharmaceuticals position peaked at $59.7M in Q4 2016.
  • 578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.